Streetbeat News

Revenues

AIRG

Airgain anticipates Q1 sales to be between $13.3M-$14.7M, surpassing the estimated $11.933M. The company also expects an adjusted EPS loss of $(0.06) at the midpoint, which is better than the estimated loss of $(0.14).

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 10:51 pm

EHAB

Enhabit projects its full-year 2024 net service revenue to be between $1.076 billion and $1.102 billion, surpassing the estimated $1.073 billion. The company also forecasts its adjusted EPS to range from $0.12 to $0.43, which is higher than the estimated $0.22.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 10:47 pm

CURLF

Curaleaf Holdings, Inc. (CURLF) reported a record Q4 revenue of $345 million, a slight year-over-year increase from $340.2 million. The company narrowed its net loss to $57.7 million, down from a larger loss in the previous year, and saw an adjusted EBITDA of $83 million. The positive results were attributed to disciplined teamwork and growth in key markets such as Arizona, Florida, New York, and Pennsylvania. For the full year, Curaleaf achieved a net revenue of $1.35 billion, a 6% increase from the previous year, with a net loss of $281.2 million.

Portfolio Pulse from Maureen Meehan

March 06, 2024 | 10:36 pm

TATT

TAT Technologies announced its full year 2023 total revenues of $113.8 million, marking a 35% increase compared to the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 10:23 pm

DSGX

Descartes Systems Gr (NASDAQ:DSGX) reported Q4 2024 earnings of $0.370 per share, meeting analyst estimates and marking an 8.82% increase from the previous year. Sales reached $148.2M, exceeding estimates by 2.96% and showing an 18.43% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 10:21 pm

SLNG

Stabilis Solutions (NASDAQ:SLNG) reported a significant increase in Q4 EPS to $0.08, up from $0.01 YoY, despite a 39% decrease in sales to $18.05M from $29.59M YoY.

Portfolio Pulse from mahesh@benzinga.com

March 06, 2024 | 10:15 pm

VMD

Viemed Healthcare anticipates its Q1 net revenues to be between $49.7M and $51M, falling short of the estimated $51.9M.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 10:13 pm

REPX

Riley Exploration Permian (REPX) reported Q4 2023 adjusted EPS of $0.70, missing the $1.60 estimate, but sales of $99.83M exceeded the $94.75M estimate, marking a 27.91% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 10:08 pm

VMD

Viemed Healthcare (NASDAQ:VMD) reported Q4 earnings of $0.09 per share, missing the consensus estimate of $0.10 by 10%. However, their quarterly sales of $50.74M exceeded the estimate of $50.00M by 1.48%, marking a 35.28% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 10:07 pm

CDMO

Avid Bioservices, Inc. (NASDAQ:CDMO) announced preliminary Q3 fiscal 2024 results with revenue of $33.8M, an 11% decrease year-over-year but a 33% increase from Q2 fiscal 2024. Despite the decrease, the company maintains its FY24 revenue guidance of $137M-$147M. The decrease in revenue and gross profit was attributed to fewer manufacturing runs and reduced process development services. However, Avid signed new orders totaling $41M, leading to a record backlog of $206M. The company also completed its cell and gene therapy facility, enhancing its service offerings and revenue capacity.

Portfolio Pulse from Happy Mohamed

March 06, 2024 | 9:52 pm